Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Mijn nieuwsbrieven
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Beurs vandaag
Amerika
Artivion Inc
Nieuws
Artivion Inc
AORT
NYS
: AORT
| ISIN: US2289031005
24/04/2024
20,92 USD
(+0,67%)
(+0,67%)
24/04/2024
Aandeel volgen
Aandeel gevolgd
Samenvatting
Nieuws
Insiders
Dividend
Technische analyse
TA
Toon enkel gratis nieuws
22 april 2024 ·
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results
· Persbericht
1 april 2024 ·
Artivion to Participate in the 23rd Annual Needham Virtual Healthcare Conference
· Persbericht
6 maart 2024 ·
Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
· Persbericht
15 februari 2024 ·
Artivion Reports Fourth Quarter and Full Year 2023 Financial Results
· Persbericht
1 februari 2024 ·
Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2023 Financial Results
· Persbericht
29 januari 2024 ·
Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 60th Society of Thoracic Surgery Annual Meeting
· Persbericht
18 januari 2024 ·
Artivion Obtains $350 Million in Senior Secured Credit Facilities
· Persbericht
6 december 2023 ·
Artivion Appoints Lance A. Berry as Executive Vice President, Chief Financial Officer; Announces Retirement of D. Ashley Lee, Chief Financial Officer
· Persbericht
9 november 2023 ·
Artivion Announces Completion of Enrollment in PERSEVERE Trial
· Persbericht
8 november 2023 ·
Artivion to Participate in Upcoming Investor Conferences
· Persbericht
2 november 2023 ·
Artivion Reports Third Quarter 2023 Financial Results
· Persbericht
19 oktober 2023 ·
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2023 Financial Results
· Persbericht
5 oktober 2023 ·
Artivion Announces Presentation of Real World Data from Post Market Study of On-X® Aortic Heart Valve Replacement Patients Treated with Low Dose Warfarin
· Persbericht
5 oktober 2023 ·
Artivion Announces Presentation of Late-Breaking Interim Data from AMDS PERSEVERE Trial at the 37th European Association for Cardio-Thoracic Surgery Annual Meeting
· Persbericht
26 september 2023 ·
Artivion to Present at the Deutsche Bank 31st Annual Leveraged Finance Conference
· Persbericht
14 september 2023 ·
Artivion to Present at the Gilmartin Group Emerging Growth Company Showcase
· Persbericht
3 augustus 2023 ·
Artivion Reports Second Quarter 2023 Financial Results
· Persbericht
1 augustus 2023 ·
Artivion to Participate in Upcoming Investor Conferences
· Persbericht
20 juli 2023 ·
Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2023 Financial Results
· Persbericht
23 mei 2023 ·
Artivion Announces FDA PMA Approval of PerClot and Transfer of PMA to Baxter
· Persbericht
Aandeel volgen
Aandeel gevolgd
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe